# Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain

> **NCT00170898** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 419 (—)

## Conditions studied

- Musculoskeletal Pain

## Interventions

- **DRUG:** Lumiracoxib

## Key facts

- **NCT ID:** NCT00170898
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 419 (—)
- **Last updated:** 2006-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00170898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00170898, "Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00170898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*